Table 5 Indicators and targets for cervical cancer prevention and control
From: Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies
Country | WHO global indicators | Country targets | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Vaccination rate | Screening rate | Screening test positivity rate | Treatment rate | Vaccination coverage | Timeline | Screening coverage | Timeline | Treatment coverage | Timeline | ||
Botswana | ✓ | ✓a | ✓a | ✓a | 98% | 2025 | 80% | 2022 | 80% | 2022 | |
Eswatini | ☓ | ☓ | ☓ | ☓ | ☓ | ☓ | ☓ | ☓ | ☓ | ☓ | |
Lesotho | ✓ | ✓ | ✓ | ✓ | 90% | ☓ | ☓ | ☓ | ☓ | ☓ | |
Malawi | ✓ | ✓a | ✓ | ✓ | 95% | 2026 | 70% | 2026 | 85% | 2026 | |
Mozambique | ☓ | ✓ | ✓a | ☓ | ☓ | ☓ | 80% | ☓ | ☓ | ☓ | |
Namibia | ✓ | ✓a | ✓a | ✓a | 95% | ☓ | 80% | 2025 | ☓ | ☓ | |
South Africa | ✓ | ✓ | ✓ | ✓ | 100% | ✓ | 65% | ☓ | ☓ | ☓ | |
Zambia | ✓ | ✓ | ✓ | ✓ | 80% | ☓ | b5-10% | Monthly | 80%:Cryotherapy: 95%:LEEP: > 80%:ICC treatment | 80% | |
Zimbabwe | ✓ | ✓ | ☓ | ☓ | 80% | 2018 | ☓ | ☓ | ☓ | 2020 | |
Other indicators disaggregated by HIV status | |||||||||||
Zimbabwe | Percentage of health facilities providing integrated HIV/STI/CC screening | Number of staff trained in integrated CC/breast/HIV/STI service per facility | Percentage of facilities with HIV/STI and cancer integrated services | Percentage of clients accessing integrated HIV/STI and cancer services | |||||||
Number of staff trained in integrated cancer/HIV/STI early detection and management services | |||||||||||